CASP3 and colonic neoplasm: The cytotoxicity of the optimized PLGA NPs was assessed against human colon cancer cell lines, HT-29, through caspase-3, vascular endothelial growth factor (VEGF), and signal transducer and activator of transcription-3 (STAT-3) proteins levels assay.